Cite
HARVARD Citation
Molina, J. et al. (2018). Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. Lancet. 5 (4), pp. e172-e180. [Online].